Cadila Healthcare receives tentative approval for oral iron chelator
Cadila Healthcare has received tentative approval from the US Food and Drug Administration (USFDA), for the oral iron chelator. The approval is for Deferasirox, which is...
Tag : Cadila Healthcare
Cadila Healthcare receives USFDA nod for Deferasirox tablets
Cadila Healthcare has received approval from the US health regulator, for Deferasirox tablets for oral suspension in the strengths of 125 mg, 250 mg and 500...
Cadila Healthcare receives USFDA nod to market Nifedipine tablets
Cadila Healthcare has received final approval to market Nifedipine extended-release tablets USP in the strengths of 30 mg, 60 mg, and 90 mg, from the US...
Cadila Healthcare receives USFDA nod for Tadalafil tablets
Cadila Healthcare has received tentative approval to market Tadalafil tablets which are available in strengths of USP, 2.5 mg, 5 mg, 10 mg and 20 mg, from...
Cadila gets USFDA nod for Doxycycline Hyclate capsules
Zydus Cadila has received final approval to market Doxycycline Hyclate Capsules USP, 50 mg and 100 mg, from the USFDA. It is a tetracycline antibiotic which is...
Cadila Healthcare gets final approval from USFDA for Carbidopa tablets
Cadila Healthcare has received final approval to market Carbidopa tablets,25 mg from USFDA. The drug is used with a combination levodopa/carbidopa product to treat symptoms of...
Cadila Healthcare gets USFDA approval for Metoprolol Succinate tablets
Cadila Healthcare has received final approval to market Metoprolol Succinate extended-release tablets, from USFDA in the strengths of 25mg, 50mg, 100mg and 200mg. The tablet will be manufactured...
Cadila Healthcare gets USFDA nod to market Tizanidine tablets
Cadila Healthcare has received final approval from USFDA, to market Tizanidine tablets USP in strengths of 2 mg and 4 mg. The tablets will be manufactured...
Cadila Healthcare reports 67.7% increase in Q3 profit
Cadila Healthcare has posted a 67.7% YoY increase in consolidated net profit, at Rs.543.3 crore. Profit for the corresponding quarter, last year was at Rs.323.9...
Cadila Healthcare receives EIR for its Ahmedabad SEZ plant
Cadila Healthcare which is a part of Zydus Cadila, has received an establishment inspection report (EIR) from USFDA for its formulation manufacturing facility at Pharma...